<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="102499">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01890460</url>
  </required_header>
  <id_info>
    <org_study_id>Baylor IRB #013-041</org_study_id>
    <nct_id>NCT01890460</nct_id>
  </id_info>
  <brief_title>Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery</brief_title>
  <acronym>SupersonicOR</acronym>
  <official_title>Quantitative Evaluation of Liver Disease With Liver Elastography Measurements Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine in Patients Undergoing Liver Transplant Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor Research Institute</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare ultrasound measurements of the liver obtained prior
      to surgery on the skin to measurements obtained during surgery directly on the diseased
      liver. The objective is to determine if ultrasounds of the liver on the skin can provide
      accurate measurements of disease of the liver to provide an alternative option to liver
      biopsies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A non-invasive, ultrasound platform based, ShearWaveTM Elastography measurement will be
      obtained at two time points on each qualified patient. The first time point will be in the
      operating room before the initial incision is made.  The second time point involves
      placement of a small, hand-held modified ultrasound probe directly on the patient's diseased
      liver during the liver transplant surgery.  The probe used in this study is the
      SuperCurvedâ„¢SC6-1, capable of a band width of 1-6MHz with 192 elements.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>To obtain quantitative evaluation of the progression of liver disease, using ShearWaveTM Elastography measurements obtained with the Supersonic Imagine Aixplorer ultrasound machine in patients undergoing a liver transplant surgery.</measure>
    <time_frame>on day of surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Liver Transplant</condition>
  <arm_group>
    <arm_group_label>Liver transplant</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Elastography Ultrasound</intervention_name>
    <arm_group_label>Liver transplant</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing a liver transplant surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and Females over the age of 18

          -  Patients undergoing a liver transplant surgery

        Exclusion Criteria:

          -  Any person unable to provide informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Trotter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor Health Care System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonnie Edwards, RN</last_name>
    <phone>214-820-6243</phone>
    <email>jonnie.edwards@baylorhealth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristy Sanders, RN, BSN</last_name>
      <phone>214-820-1737</phone>
    </contact>
    <contact_backup>
      <last_name>Jordyn Talley</last_name>
      <phone>214-818-7815</phone>
    </contact_backup>
    <investigator>
      <last_name>James Trotter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 21, 2014</lastchanged_date>
  <firstreceived_date>June 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
